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Abstract
The outcome of microbial infection of insects is dependent not only on interactions between the host and pathogen, but
also on the interactions between microbes that co-infect the host. Recently the maternally inherited endosymbiotic bacteria
Wolbachia has been shown to protect insects from a range of microbial and eukaryotic pathogens. Mosquitoes
experimentally infected with Wolbachia have upregulated immune responses and are protected from a number of
pathogens including viruses, bacteria, Plasmodium and filarial nematodes. It has been hypothesised that immune
upregulation underpins Wolbachia-mediated protection. Drosophila is a strong model for understanding host-Wolbachia-
pathogen interactions. Wolbachia-mediated antiviral protection in Drosophila has been demonstrated for a number of
different Wolbachia strains. In this study we investigate whether Wolbachia-infected flies are also protected against
pathogenic bacteria. Drosophila simulans lines infected with five different Wolbachia strains were challenged with the
pathogenic bacteria Pseudomonas aeruginosa PA01, Serratia marcescens and Erwinia carotovora and mortality compared to
paired lines without Wolbachia. No difference in mortality was observed in the flies with or without Wolbachia. Similarly no
antibacterial protection was observed for D. melanogaster infected with Wolbachia. Interestingly, D. melanogaster Oregon
RC flies which are naturally infected with Wolbachia showed no upregulation of the antibacterial immune genes TepIV,
Defensin, Diptericin B, PGRP-SD, Cecropin A1 and Attacin D compared to paired flies without Wolbachia. Taken together
these results indicate that Wolbachia-mediated antibacterial protection is not ubiquitous in insects and furthermore that the
mechanisms of antibacterial and antiviral protection are independent. We suggest that the immune priming and
antibacterial protection observed in Wolbachia-infected mosquitoes may be a consequence of the recent artificial
introduction of the symbiont into insects that normally do not carry Wolbachia and that antibacterial protection is unlikely
to be found in insects carrying long-term Wolbachia infections.
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Introduction
The interaction between two microbes within a host can impact
on the outcome of infection for the host. Wolbachia are a
maternally transmitted endosymbiotic a-proteobacteria that is
predicted to infect up to 70% of insect species [1,2]. Wolbachia can
protect insects from infection by a range of microbes and parasites
[3–10]. Where the microbes are pathogens of the insect, this
protection has the potential to greatly influence the ecology of the
host, pathogen and Wolbachia [11–13]. In addition, it has been
widely suggested that Wolbachia-mediated pathogen protection
could be harnessed in biological control programs to interfere with
the transmission of human diseases that are vectored by insects,
including dengue and malaria. However, the molecular mecha-
nisms involved in protection are yet to be determined.
Mosquitoes that are experimentally infected with Wolbachia are
protected from a range of viruses, bacteria and parasites. A
number of mosquito species that are important human disease
vectors are not naturally found to be infected with Wolbachia,f o r
example Aedes aegypti and Anopheles species. However, utilising
transinfection techniques Ae. aegypti has been experimentally
infected with Wolbachia strains wMelPop-CLA or wAlbB [14,15].
The mosquitoes stably infected with Wolbachia accumulate and
transmit RNA viruses such as Dengue and Chikungunya less
readily than Wolbachia-free mosquitoes [3,8]. Infection of Ae.
aegypti with the D. melanogaster derived Wolbachia strain wMelPop-
CLA also reduced the prevalence of the filarial nematode Brugia
pahangi, impaired the ability to transmit the avian malarial
parasite Plasmodium gallinaceum. In addition reduced mortality
induced by infection with the Gram-negative bacterium Erwinia
caratovora but not the Gram-positive bacteria Micrococcus luteus was
observed in these mosquitoes [7]. In addition, whilst stable
transinfection of Anopheles mosquitoes is yet to be achieved, An.
gambiae that were somatically infected with Wolbachia showed
reduced accumulation of Plasmodium oocysts [5,6]. Thus in
mosquitoes, artificially introduced Wolbachia induces broad
ranging antipathogen protection.
The phenomenon of Wolbachia-mediated antiviral protection is
well established in the model insect Drosophila. Naturally Wolbachia-
infected flies are protected from a diverse range of RNA viruses
[4,10]. In the case of the pathogenic viruses Drosophila C virus
(DCV), Flock House virus (FHV) and Cricket paralysis virus (CrPV)
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unprotected Wolbachia-free counterparts [4,10]. This protection
has been shown to be consistent across the closely related
Wolbachia strains that infect D. melanogaster (wMel, wMelCS and
wMelPop) and across different host backgrounds [4,10]. Wolbachia
antiviral protection has also been demonstrated in the related
species D. simulans [9].
Not all Wolbachia:host combinations result in antiviral protec-
tion. D. simulans are naturally infected with diverse Wolbachia
strains from both supergroup A (wAu, wRi and wHa) and B (wNo)
[16,17]. D. simulans lines naturally infected with wAu and wRi (line
CO and DSR respectively) are protected from DCV and FHV,
whereas those naturally infected with wHa and wNo (line DSH
and N7NO respectively) are not protected [9]. In these fly lines
antiviral protection correlates with both phylogenetic relatedness
to wMel and also high density of Wolbachia in the host [9]. The D.
simulans line Me29, which was transinfected with wMel in 1998
[18], is also protected from both DCV and FHV infection.
The mechanism(s) of Wolbachia-mediated protection have not
been determined. The correlation between density and distribu-
tion of Wolbachia in flies and mosquitoes supports the hypothesis
that Wolbachia and pathogens may be in competition for limited
host resources [8,9]. Alternatively several studies have demon-
strated that antipathogen protection in experimentally infected
mosquitoes is concomitant with Wolbachia induced upregulation of
a range of host immune genes [3,5–8]. Genes involved in the
antimicrobial IMD and Toll pathways are upregulated, with the
effector genes such as cecropins and other antimicrobial peptides
(AMPs) showing the highest upregulation. These observations led
to the hypothesis that Wolbachia infection primes the immune
system so that when Wolbachia-infected insects are challenged with
a pathogen the insect is protected from the pathogen. Little direct
evidence is available in support of this hypothesis, although in
somatically infected An. gambiae upregulation of Tep1 has been
experimentally linked with protection against parasite P. berghei [6]
and Dengue virus is somewhat impacted by upregulation of the
Toll pathway [19].
In contrast to mosquitoes, it is less clear if Wolbachia stimulates
immune priming in Drosophila. Cultured D. melanogaster cells (S2 cell
line) showed upregulation of genes from the Toll and IMD
pathways as well as AMP effector molecules when experimentally
infected with the Wolbachia wRi strain (which naturally infects D.
simulans) [20]. In contrast, an early study using Northern blot
analysis found no difference in cecropin or diptericin RNA levels
in D. simulans line DSR with and without wRi infection and
similarly no difference was recorded for Defensin expression in Ae.
albopictus with and without Wolbachia infection [21]. It remains to
be confirmed whether Wolbachia-mediated immune priming is
linked to the antiviral protection that has been documented in
Drosophila.
In mosquitoes Wolbachia mediates protection against a range of
pathogens, yet it is unclear whether a single molecular mechanism
underpins protection against this diverse group of microbes and
parasites. In Drosophila not all host:Wolbachia combinations protect
against virus infection [9]. If the mechanism that underlies
protection were the same for bacteria and viruses we would predict
that those Drosophila:Wolbachia combinations with reduced virus-
induced mortality would similarly reduce pathogenic bacterial
infection.
In this study we investigated whether antibacterial protection
occurs in flies infected with Wolbachia. To do this five D.
simulans:Wolbachia lines were utilised that we previously used to
investigate antiviral protection. Bacterial pathogens Pseudomonas
aeruginosa PA01, Serratia marcescens and E. carotovora were used to
challenge the flies. P. aeruginosa PA01 and S. marcescens are the
opportunistic and natural pathogens of Drosophila respectively
[22,23] and Wolbachia mediates protection in Ae. aegypti against
mortality induced by E. carotovora [7]. Further, using reverse
transcription and quantitative PCR to assay expression of six
AMPs and immune genes there was no evidence of antibacterial
immune priming in D. melanogaster naturally infected with
Wolbachia.
Results
Wolbachia does not protect D. simulans from pathogenic
bacteria
The impact of Wolbachia on the outcome of virus infection varies
in D. simulans lines challenged with RNA viruses. D. simulans lines
CO, DSR and Me29 are protected against DCV and FHV
infections by Wolbachia strains wAu, wRi and wMel respectively. In
contrast, D. simulans lines DSH and N7NO are not protected
against DCV and FHV infections by wHa and wNo respectively
[9]. In order to investigate whether these Wolbachia strains confer
protection to D. simulans lines challenged with pathogenic bacteria,
D. simulans CO, DSR, Me29, DSH and N7NO lines with
Wolbachia and paired lines that had been cured of Wolbachia
infection were challenged with three pathogenic Gram-negative
bacteria (P. aeruginosa PA01, S. marcescens and E. carotovora) and
mortality recorded for up to 36 hours.
Mortality of CO flies challenged with pathogenic bacteria was
similar regardless of Wolbachia infection status (Figure 1). Flies both
with and without Wolbachia challenged with P. aeruginosa PA01 died
within 25 hours of infection and there was no significant difference
in the survival curves (Figure 1 A; p=0.2). In this and all other
experiments there was negligible mortality of mock-infected flies
during the time course. S. marcescens and E. carotovora are more
virulent than P. aeruginosa PA01. After infection, flies with and
without Wolbachia died within 15 hours (Figure 1 B and C).
Statistical analysis showed that there was no significant difference
in survival of flies with and without Wolbachia (p=0.3 for S.
marcescens infection, p=0.0533 for E. carotovora infection). Each
survival bioassay was independently repeated at least three times
with similar results (data not shown). These results indicate that
while wAu infection of CO flies protects the flies from viral-
induced mortality there is no protection against pathogenic
bacteria mediated by wAu.
To investigate whether lack of protection in D. simulans was
limited to this particular host:Wolbachia combination we chal-
lenged four other fly lines with and without Wolbachia with the
three pathogenic bacteria. DSR, Me29, DSH and N7NO that
were challenged with P.aeruginosa PA01 died within 25 to 30 hours
post infection (Figure 2 A, 3 A, 4 A and 5 A). D. simulans DSR,
Me29, DSH and N7NO when challenged with S. marcescens and E.
carotovora, died within 10 to 25 hours post infection (Figure 2 B and
C, 3 B and C, 4 B and C, 5 B and C). In each assay there was no
difference between the survival curves of flies with and without
Wolbachia challenged with each of the pathogenic bacteria
(p.0.05). Results shown are representative of at least three
independent bioassays, each with similar results obtained. The
survival bioassays were also repeated with at least two independent
experiments with a lower concentration of bacterial culture
(O.D.600 nm=0.1–0.5) (data not shown). At this lower concentra-
tion of bacteria, 100% mortality was not achieved in most cases,
however, there was still no protection against bacterial-induced
mortality. Taken together these results give strong evidence that
Wolbachia does not confer protection in D. simulans against
bacterial-induced mortality.
Wolbachia-Mediated Antibacterial Protection
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in D. melanogaster
In contrast to Ae. aegypti mosquitoes [7] our results show that
there is no antibacterial protection mediated by Wolbachia in D.
simulans. To investigate whether lack of protection was restricted
to this single species we utilised the D. melanogaster line ORC in
protection bioassays. This species was chosen as Wolbachia has
been shown to protect D. melanogaster from a number of different
viral pathogens [4,9,10]. ORC flies with and without wMelCS
were challenged with P. aeruginosa PA01, S. marcescens and E.
carotovora and survival was monitored (Figure 6). There was no
difference in the survival of flies with and without Wolbachia in
response to S. marcescens challenge (p=0.3). ORC flies with
Wolbachia were somewhat more susceptible to P. aeruginosa PA01
and E. carotovora than flies without Wolbachia (p,0.05) in the
results shown in Figure 6. However, this small difference was
only observed in one out of three experiments, suggesting that if
Figure 1. Survival of D. simulans CO flies challenged with
pathogenic bacteria. Graphs show the survival of D. simulans CO flies
with (cross) and without (triangle) wAu challenged with (A) P.
aeruginosa PA01, (B) S. marcescens and (C) E. carotovora. Flies were
infected with pathogenic bacteria (black line) or mock infected with LB
(grey line). Error bars represent SEM calculated from three replicate
vials.
doi:10.1371/journal.pone.0025430.g001
Figure 2. Survival of D. simulans DSR flies challenged with
pathogenic bacteria. Graphs show the survival of D. simulans DSR
flies with (cross) and without (triangle) wRi challenged with (A) P.
aeruginosa PA01, (B) S. marcescens and (C) E. carotovora. Flies were
infected with pathogenic bacteria (black line) or mock infected with LB
(grey line). Error bars represent SEM calculated from three replicate
vials.
doi:10.1371/journal.pone.0025430.g002
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show that natural infection with Wolbachia does not confer
protection against pathogenic bacteria-induced mortality in D.
melanogaster.
Analysis of in vivo bacterial growth in D. melanogaster
Taken together, results obtained from survival bioassays of all D.
simulans and D. melanogaster challenged with pathogenic bacteria
indicate that Wolbachia does not mediate protection against
mortality induced by pathogenic bacteria in Drosophila. In order
to investigate whether Wolbachia affects the in vivo accumulation of
pathogenic bacterial load in Drosophila the D. melanogaster ORC line
was challenged with P. aeruginosa PA01. Samples were collected at
0 and 12 hours post infection and bacterial load was analysed. In
flies that were not challenged with P. aeruginosa PA01 no bacterial
colonies grew on the selective LB-Ampicillin plates, indicating that
all colonies identified in challenged flies arose from antibiotic
Figure 3. Survival of D. simulans Me29 flies challenged with
pathogenic bacteria. Graphs show the survival of D. simulans Me29
with (cross) and without (triangle) wMel challenged with (A) P.
aeruginosa PA01, (B) S. marcescens and (C) E. carotovora. Flies were
infected with pathogenic bacteria (black line) or mock infected with LB
(grey line). Error bars represent SEM calculated from three replicate
vials.
doi:10.1371/journal.pone.0025430.g003
Figure 4. Survival of D. simulans DSH flies challenged with
pathogenic bacteria. Graphs show the survival of D. simulans DSH
infected with (cross) and without (triangle) wHa challenged with (A) P.
aeruginosa PA01, (B) S. marcescens and (C) E. carotovora. Flies were
infected with pathogenic bacteria (black line) or mock infected with LB
(grey line). Error bars represent SEM calculated from three replicate
vials.
doi:10.1371/journal.pone.0025430.g004
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were 1.0–3.5610
3 CFU/fly, indicating that this was the dose with
which the flies were challenged (Figure 7). At 12 hours post
infection the bacterial load had increased by 3 orders of magnitude
to approximately 1.0610
6 CFU/fly. Similar bacterial loads were
observed in both flies with and without Wolbachia indicating that
there was no difference in the accumulation of the P. aeruginosa
PA01.
Regulation of immune genes in D. melanogaster in
response to Wolbachia infection
Wolbachia has been shown to stimulate different immune gene
responses in different Wolbachia:host combinations [6–8,20,21,
24,25] and it has been suggested that immune priming stimulated
by Wolbachia may be causally linked to Wolbachia-mediated
antipathogen protection [3,6–8]. Given no antibacterial protection
was mediated in the six host:Wolbachia combinations utilised in this
study we wanted to investigate whether antibacterial immune
Figure 5. Survival of D. simulans N7NO challenged with
pathogenic bacteria. Graphs show the survival of D. simulans
N7NO with (cross) and without (triangle) wNo challenged with (A) P.
aeruginosa PA01, (B) S. marcescens and (C) E. carotovora. Flies were
infected with pathogenic bacteria (black line) or mock infected with LB
(grey line). Error bars represent SEM calculated from three replicate
vials.
doi:10.1371/journal.pone.0025430.g005
Figure 6. Survival of D. melanogaster Oregon RC challenged
with pathogenic bacteria. Graphs show the survival of D.
melanogaster ORC with (cross) and without (triangle) wMelCS chal-
lenged with (A) P. aeruginosa PA01, (B) S. marcescens and (C) E.
carotovora. Flies were infected with pathogenic bacteria (black line) or
mock infected with LB (grey line). Error bars represent SEM calculated
from three replicate vials.
doi:10.1371/journal.pone.0025430.g006
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The regulation of six immune genes in D. melanogaster ORC flies
with and without Wolbachia was investigated using RT-qPCR.
These genes were chosen as they were homologous to genes that
were upregulated by Wolbachia presence in Ae. aegypti [7]. None of
the six immune genes that were investigated in Drosophila (TepIV,
Defensin, Diptericin B, PGRP-SD, Cecropin A1 and Attacin D)
were differentially regulated in the presence of Wolbachia (p,0.05;
Figure 8).
Discussion
The lack of Wolbachia-mediated antibacterial protection in
Drosophila differs from studies in mosquitoes where Wolbachia has
been shown to mediate broad-spectrum anti-microbe and -parasite
protection [3,5–8]. In mosquitoes experimentally infected with
Wolbachia there is upregulation of a number of genes for immune
effector molecules and those involved in antimicrobial pathways
[3,7,8]. It has been suggested that this Wolbachia induced ‘‘immune
priming’’ may be the mechanism underlying protection and some
evidence has been presented for this for anti-Plasmodium protection
[6]. We reasoned that as Wolbachia-infected Drosophila were not
protected from pathogenic Gram-negative bacteria, this may be
because Wolbachia was not stimulating an immune response in
these flies. To assess this we analysed the expression of six
antimicrobial immune genes whose homologues were upregulated
in Wolbachia-infected mosquitoes [7]. In D. melanogaster Wolbachia
infection did not stimulate expression of the antimicrobial response
genes.
It is interesting that Wolbachia differentially stimulates immune
responses in different hosts. The host:Wolbachia examples
discussed above differ in two ways. Firstly, the hosts are from
different insect families: mosquitoes and flies. But perhaps more
importantly each analysis of immune regulation has been
performed using mosquitoes that have been recently experimen-
tally infected with Wolbachia. In contrast the D. melanogaster ORC
line used here, is naturally infected with Wolbachia.A sa
Figure 7. In vivo bacterial growth of P. aeruginosa PA01 D.
melanogaster ORC adults with and without Wolbachia infection.
Graph shows the number of bacteria per fly (CFU/fly) of P. aeruginosa
PA01 in D. melanogaster without (triangle) and with wMelCS (cross) at
time 0 and 12 hours post infection.
doi:10.1371/journal.pone.0025430.g007
Figure 8. Immune gene expression in response to Wolbachia infection. The relative expression (RE) of immune genes of D. melanogaster with
and without Wolbachia was analysed using RT-qPCR. The box and whisker plots show the ratio of immune to reference gene (RpL32) expression from
the indicated genes: (A) Attacin D, (B) Diptericin B, (C) Cecropin A1, (D) Defensin, (E) PGRP-SD and (F) TepIV. Boxes represent medians, 25 (bar below
median) and 75 (above median) percentiles of 10 individual male flies. None of the medians were significantly different (Mann Whitney-U test;
p.0.05).
doi:10.1371/journal.pone.0025430.g008
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association with its host from generation to generation. Co-
evolution of the bacteria and host is postulated to eventuate in
commensal or mutualistic associations. Experimental introduc-
tion of Wolbachia into a new host can lead to over-replication of
the bacteria and pathogenicity, although these effects can be
ameliorated in later generations [5,26,27]. This raises the
possibility that Wolbachia induced immune priming is a conse-
quence of maladapted interactions following experimental
introduction of Wolbachia into a new host. This premise is
supported by previous studies that show upregulation of immune
genes in D. melanogaster cell line S2 experimentally infected with D.
simulans derived Wolbachia strain wRi [20], but not in D. simulans
flies which were naturally infected with wRi or Ae. albopictus
naturally infected with wAlbB [21]. Further some natural
Wolbachia infections can depress antibacterial immunity [25]. It
should be noted that the D. simulans Me29 line used in the present
study is artificially infected with the D. melanogaster derived
Wolbachia strain wMel. We suggest that the lack of antibacterial
protection in the Me29 line may be a consequence of adaptation
that has occurred during the 13 or more years since this line was
established [18]. Thus both the data presented here and
previously is consistent with Wolbachia-mediated immune priming
being important for antibacterial and antiparasite protection in
hosts artificially infected with Wolbachia.
This study investigated Wolbachia-mediated antibacterial pro-
tection by utilising three Gram-negative bacterial challenge
models. It is possible that the protection response upon challenge
with a Gram-positive bacterium may differ from that observed in
this study. However, we consider this to be unlikely given the lack
of protection against Gram-positive bacteria in mosquitoes [7]
and lack of Wolbachia-mediated immune stimulation observed in
naturally Wolbachia-infected Drosophila.
The immune pathways Toll, IMD and AMPs showed no
evidence of antibacterial immune priming by Wolbachia in D.
simulans [21] or D. melanogaster, and no protection against bacterial
infection was observed. Given that antiviral protection has been
demonstrated using the same Drosophila lines as used in the current
study [4,9], our results indicate that stimulation of the Toll, IMD
or AMPs pathways are not necessary for Wolbachia stimulated
antiviral mechanisms. This leaves other immune pathways, such as
Vago and vir-1 [28,29], the major insect viral-defence RNA
silencing pathway [30] or competition for host resources as
potential Wolbachia-mediated antiviral responses. As Wolbachia-
mediated antiviral protection occurs in both naturally and
experimentally infected hosts [3,4,8–10,31] its likely to occur
through a conserved mechanism that is independent of that
involved in protection against other pathogens.
Wolbachia-mediated antiviral protection in Drosophila has been
shown to be robust. Antiviral protection is observed against
many different RNA viruses including both natural pathogens
of Drosophila and viruses that normally infect mosquito vectors
or other insects [4,9,10,32]. In addition, several different
Wolbachia strains have been shown to protect flies from viruses
in a number of different lines of both D. simulans and D.
melanogaster [4,9]. In stark contrast, we show here that Wolbachia
does not mediate protection against pathogenic bacteria in
Drosophila. We have demonstrated this using three different
Gram-negative bacterial pathogens and six different Wolbachia:-
Drosophila combinations, including both D. simulans and D.
melanogaster hosts. These results have implications both for the
potential mechanisms of and uses for Wolbachia-mediated
protection.
Materials and Methods
Flies and Wolbachia
All fly lines were maintained on standard cornmeal diet at 25uC
with 12-hours light/dark cycle and were sourced from the lab fly
collection. The D. melanogaster line Oregon RC (ORC) is naturally
infected with Wolbachia strain wMelCS [33]. The D. simulans lines
CO, DSR, N7NO and DSH are naturally infected with Wolbachia
strains wAu [34], wRi [35], wNo [36] and wHa [37] respectively.
The D. simulans line Me29 was experimentally infected with wMel
over a decade ago by transinfection of NAaTC embryos with
wMel from D. melanogaster embryos [18]. Wolbachia-free lines were
generated from each of the fly lines as previously described [4,9].
Pathogenic bacteria
Three Gram-negative bacteria that are pathogens of Drosophila
were used in challenge experiments. S. marcescens and E. carotovora
were grown in LB medium [23]. P. aeruginosa PA01 carries an
ampicillin resistance gene and was grown in LB medium
supplemented with 100 mg/ml ampicillin [38]. To prepare
bacteria for challenge bioassays, LB broth was inoculated with
bacteria from single colonies on agar plates and incubated for
16 hours at 37uC. Bacteria were then pelleted by centrifugation at
1,5006 g for 10 minutes at room temperature. Fresh bacterial
pellets were prepared for each infection bioassay.
Survival bioassays
To analyse the susceptibility of flies with and without Wolbachia
to bacterial induced mortality, 4–7 day old adult male Drosophila
were challenged with each of the pathogenic bacteria. Flies were
anaesthetised with CO2 prior to infection. A thin needle
(diameter=0.193 mm) was dipped into the undiluted bacterial
pellet and used to prick into the thoracic region of each fly. For
each fly line, two groups of flies were challenged with pathogenic
bacteria: flies with Wolbachia and flies without Wolbachia. For each
group of flies three vials of ten flies were challenged with one of the
pathogenic bacteria and one vial of ten flies was mock infected
with LB medium. Following challenge flies were maintained in a
25uC incubator and survival of the flies was monitored every 2–
6 hours. Mortality within the first 6 hours was deemed to be due
to needle injury. At least three independent survival bioassays were
done for each bacteria/fly line combination. Survival curves of the
two groups of flies were compared using Kaplan-Meier analysis
and log-rank statistics reported (GraphPad Prism).
In vivo bacterial growth
To analyse the impact of Wolbachia on the accumulation of
pathogenic bacteria in flies, 4–7 day old adult male ORC flies with
and without Wolbachia were infected with P. aeruginosa PA01 as
described above. At 0 and 12 hpi, three live flies were collected
individually into 1.5 ml tubes. After addition of 200 mlo fL B
medium supplemented with 100 mg/ml ampicillin and two 3 mm
glass beads (Sigma-Aldrich) to each individual, flies were
homogenised for 90 s using a TissueLyser II (Qiagen). Fly
homogenates were serially diluted and spread on LB agar plates
containing 100 mg/ml ampicillin. Colony forming units per fly
(CFU/fly) were calculated after overnight incubation of plates.
The experiment was replicated on two independent cohorts of flies
and the data pooled.
Analysis of immune gene regulation
RT-qPCR was used to compare the expression of six immune
genes in ORC flies with and without Wolbachia. Genes were chosen
on the basis of homology to genes that were upregulated in Ae.
Wolbachia-Mediated Antibacterial Protection
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genes (Table S1) were designed with Primer3 software [39]. The
primer efficiency across a six 5-fold cDNA dilution series was
confirmed [40].
For comparison of gene regulation five individual 4–7 day old
male flies from the ORC flies with and without Wolbachia were
frozen and homogenised in Ribozol (Amesco) with two 3 mm glass
beads using TissueLyser II (Qiagen) for 90 seconds with the
frequency of 30 shakes/s. Total RNA was extracted and treated
with DNase (Promega) for 30 minutes at 37uC to eliminate DNA
contamination. 1 mg of total RNA was reverse transcribed using
random primers (Promega) and SuperScript III reverse transcrip-
tase (Invitrogen) as per the manufacturer’s protocol. Quantitative
PCR was performed in duplicate reactions using Platinum SYBRH
green qPCR supermix as per manufacturers instructions (Invitro-
gen). The temperature profile for the qPCR was 95uC for 2 min,
50uC for 2 min and 40 cycles of 95uC for 10 s, 60uC for 10 s and
72uC for 20 s. qPCR was performed using a Rotor-Gene 6000
(Qiagen). Expression of the target genes was normalised using
reference genes Actin 79b (GenBank accession no. NM_079486)
and ribosomal protein L 32 (RpL 32) (Genbank accession
no. NM_001144656.2) [41]. Target to reference gene ratios were
obtained suing QGene4.2 [42] and treatment effects on the
expression ratios were assessed using Mann Whitney-U tests in
STATISTICA V8 (StatSoft).
Supporting Information
Table S1 RT-qPCR primers.
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